Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 13 years
- Director since
- 2023
13 years of board service in total across 4 boards, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
GeneDx Holdings Corp.
Director
Fluent Inc.
Director
OPKO Health Inc.
Director
Cocrystal Pharma Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cocrystal Pharma Inc. July 14, 202691.7%
-
OPKO Health Inc. June 18, 202691.5%
-
Fluent Inc. June 17, 202699.2%
-
Cocrystal Pharma Inc. June 25, 202596.4%
-
Fluent Inc. June 18, 202596.9%
-
OPKO Health Inc. April 23, 202598.7%
-
Cocrystal Pharma Inc. June 25, 202482.6%
-
GeneDx Holdings Corp. June 20, 202496.8%
-
Fluent Inc. June 5, 202495.6%
-
OPKO Health Inc. March 28, 202494.1%
-
OPKO Health Inc. June 22, 202382.2%
-
Fluent Inc. June 9, 202378.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | GeneDx Holdings Corp. | Option exercise | +3,576 | — | — |
| Jun 17, 2026 | Fluent Inc. | Grant or award | +30,096 | — | — |
| Oct 28, 2025 | Cocrystal Pharma Inc. | Grant or award | +20,000 | — | — |
| Jun 18, 2025 | GeneDx Holdings Corp. | Option exercise | +12,924 | — | — |
| Jun 18, 2025 | Fluent Inc. | Grant or award | +39,682 | — | — |
| May 2, 2025 | GeneDx Holdings Corp. | Option exercise | +918 | — | — |
| Oct 9, 2024 | Cocrystal Pharma Inc. | Grant or award | +8,067 | — | — |
| Jun 20, 2024 | GeneDx Holdings Corp. | Option exercise | +5,828 | — | — |
| Jun 5, 2024 | Fluent Inc. | Grant or award | +21,429 | — | — |
| May 2, 2024 | GeneDx Holdings Corp. | Option exercise | +918 | — | — |
| Jan 5, 2024 | OPKO Health Inc. | Open-market purchase | +13,000 | $0.93 | $12,090 |
| Jan 5, 2024 | OPKO Health Inc. | Open-market purchase | +12,000 | $0.95 | $11,400 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
| Nov 13, 2023 | OPKO Health Inc. | Open-market purchase | +5,000 | $1.30 | $6,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.